| Economic burden of community‐based disease‐associated malnutrition in the United States JT Snider, MT Linthicum, Y Wu, C LaVallee, DN Lakdawalla, R Hegazi, ... Journal of Parenteral and Enteral Nutrition 38, 77S-85S, 2014 | 111 | 2014 |
| Effect of hospital use of oral nutritional supplementation on length of stay, hospital cost, and 30-day readmissions among Medicare patients with COPD JT Snider, AB Jena, MT Linthicum, RA Hegazi, JS Partridge, C LaVallee, ... Chest 147 (6), 1477-1484, 2015 | 93 | 2015 |
| Economic burden of disease-associated malnutrition in China MT Linthicum, J Thornton Snider, R Vaithianathan, Y Wu, C LaVallee, ... Asia Pacific Journal of Public Health 27 (4), 407-417, 2015 | 35 | 2015 |
| Impact of oral nutrition supplements on hospital outcomes in pediatric patients DN Lakdawalla, M Mascarenhas, AB Jena, J Vanderpuye‐Orgle, ... Journal of Parenteral and Enteral Nutrition 38, 42S-49S, 2014 | 33 | 2014 |
| Value of expanding HCV screening and treatment policies in the United States MT Linthicum, YS Gonzalez, K Mulligan, GA Moreno, D Dreyfus, T Juday, ... Am J Manag Care 22 (6), 227-35, 2016 | 31 | 2016 |
| Cancer mortality reductions were greatest among countries where cancer care spending rose the most, 1995–2007 W Stevens, TJ Philipson, ZM Khan, JP MacEwan, MT Linthicum, ... Health affairs 34 (4), 562-570, 2015 | 31 | 2015 |
| Putting stakeholder engagement at the center of health economic modeling for health technology assessment in the United States RZ Xie, EF Malik, MT Linthicum, JL Bright Pharmacoeconomics 39 (6), 631-638, 2021 | 28 | 2021 |
| Evaluating expected costs and benefits of granting access to new treatments on the basis of progression-free survival in non–small-cell lung cancer DN Lakdawalla, JW Chou, MT Linthicum, JP MacEwan, J Zhang, ... JAMA oncology 1 (2), 196-202, 2015 | 25 | 2015 |
| Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996–2009 DP Goldman, T Juday, D Seekins, MT Linthicum, JA Romley Health affairs 33 (3), 362-369, 2014 | 25 | 2014 |
| Data-driven decision-making tools to improve public resource allocation for care and prevention of HIV/AIDS GW Ryan, EW Bloom, DJ Lowsky, MT Linthicum, T Juday, L Rosenblatt, ... Health Affairs 33 (3), 410-417, 2014 | 21 | 2014 |
| Developing open-source models for the US health system: practical experiences and challenges to date with the open-source value project JP Jansen, D Incerti, MT Linthicum Pharmacoeconomics 37 (11), 1313-1320, 2019 | 17 | 2019 |
| The prospect of a generation free of HIV may be within reach if the right policy decisions are made DP Goldman, T Juday, MT Linthicum, L Rosenblatt, D Seekins Health Affairs 33 (3), 428-433, 2014 | 16 | 2014 |
| Costs and spillover effects of private insurers' coverage of hepatitis C treatment GA Moreno, K Mulligan, C Huber, MT Linthicum, D Dreyfus, T Juday, ... Am J Manag Care 22 (6), 2016 | 11 | 2016 |
| Can oral nutritional supplements improve Medicare patient outcomes in the hospital? DN Lakdawalla, JT Snider, DJ Perlroth, C LaVallee, MT Linthicum, ... Forum for Health Economics and Policy 17 (2), 131-151, 2014 | 11 | 2014 |
| Tutorial on health economics and outcomes research in nutrition T Philipson, MT Linthicum, JT Snider Journal of Parenteral and Enteral Nutrition 38, 5S-16S, 2014 | 10 | 2014 |
| The importance of collaboration in pursuit of patient-centered value assessment MT Linthicum, S dosReis, JF Slejko, TJ Mattingly, JL Bright The Patient-Patient-Centered Outcomes Research 14, 381-384, 2021 | 7 | 2021 |
| Greater spending associated with improved survival for some cancers in OCM-Defined episodes J Baumgardner, A Shahabi, M Linthicum, S Vine, C Zacker, D Lakdawalla Journal of Managed Care & Specialty Pharmacy 24 (6), 504-513, 2018 | 6 | 2018 |
| Gene drive debate must include voices from Africa, elsewhere RN Kamwi, AV Holmes, MM Abaza, L Husten, J Bright, M Linthicum STAT [Internet] 15, 2016 | 6 | 2016 |
| An open-source consensus-based approach to value assessment JP Jansen, D Incerti, MT Linthicum Health Affairs Forefront, 2017 | 5 | 2017 |
| Regulatory, legal uncertainties are barriers to value-based agreements for drugs AS Ward, MT Linthicum, M Drozd, AR Silverstein, J Vandigo Health Affairs Forefront, 2016 | 5 | 2016 |
Dana P GoldmanSol Price School of Public Policy, University of Southern CaliforniaVerified email at usc.edu
